Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Patient #19

<< Previous

Bullboard Posts

Next >>

Post by 99942Apophison Sep 06, 2021 6:19am

559 Views

Post# 33816266

Patient #19

Patient #19 announced in news release dated May 28 plus 90 days +7 days puts him/her into this week although I don't expect CR to be announced for one patient. Also patient #20 was announced June 11 plus 90 days + 7 days puts that patient into the week of Sept 20, perhaps but not guaranteed Theralase might announce results of those 2 patients. This new interim CEO seems to be more shareholder friendly.

<< Previous

Bullboard Posts

Next >>

Understanding tax loss season and the “Santa Claus rally”